Approval · Notice of Compliance 24908 · 2020
CORZYNA: Notice of Compliance 24908
Issued December 31, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24908
- Date
- December 31, 2020
- Company
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
Medicinal ingredients
- RANOLAZINE 500 MG per TAB
- RANOLAZINE 1,000 MG per TAB